Modern Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$351K Buy
1,625
+96
+6% +$18.4K ﹤0.01% 820
2026
Q1
$281K Sell
1,529
-4
-0.3% -$737 ﹤0.01% 737
2025
Q4
$270K Buy
1,533
+26
+2% +$4.25K ﹤0.01% 715
2025
Q3
$211K Buy
+1,507
New +$204K ﹤0.01% 754

Other funds holding BIIB

Modern Wealth Management's BIIB Position: Q2 2026 in Review

Modern Wealth Management increased its Biogen (BIIB) stake by 6.3% in Q2 2026, buying an estimated $18.4K and bringing the position to 1,625 shares worth $351K. The position accounts for ﹤0.01% of the portfolio, ranked #820.

Modern Wealth Management first reported a position in BIIB in Q3 2025 and has held it in 4 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Modern Wealth Management held 1,625 shares of Biogen worth $351K as of Q2 2026.
  • Modern Wealth Management bought 96 Biogen shares in Q2 2026, an estimated $18.4K.
  • Biogen made up ﹤0.01% of Modern Wealth Management's portfolio in Q2 2026, its #820 holding.
  • Modern Wealth Management first reported a position in Biogen in Q3 2025 and has held it in 4 quarters since.
  • 1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Modern Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.